Journal
JOURNAL OF CONTROLLED RELEASE
Volume 353, Issue -, Pages 699-712Publisher
ELSEVIER
DOI: 10.1016/j.jconrel.2022.12.028
Keywords
Ultra -small nanoparticles; Size -shrinkable; Drug delivery; Tumor permeation; Cancer treatment
Ask authors/readers for more resources
With the development of nanotechnology, nanomedicines are widely used in tumor therapy. However, biological barriers in the delivery of nanoparticles still limit their application in tumor therapy. In order to overcome this limitation, the use of ultra-small nanoparticles is proposed, which can facilitate deep tumor penetration and uniform drug distribution. This review systematically summarizes the latest progresses and advantages of ultra-small nanoparticles, as well as discusses the perspectives and challenges of their strategy for cancer treatment.
With the development of nanotechnology, nanomedicines are widely used in tumor therapy. However, biological barriers in the delivery of nanoparticles still limit their application in tumor therapy. As one of the most fundamental properties of nanoparticles, particle size plays a crucial role in the process of the nanoparticles delivery process. It is difficult for large size nanoparticles with fixed size to achieve satisfactory outcomes in every process. In order to overcome the poor penetration of larger size, nanoparticles with ultra-small particle size are proposed, which are more conducive to deep tumor penetration and uniform drug distribution. In this review, the latest progresses and advantages of ultra-small nanoparticles are systematically summarized, the perspectives and challenges of ultra-small nanoparticles strategy for cancer treatment are also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available